{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T15:51:27Z","timestamp":1789055487159,"version":"build-2803163510"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T00:00:00Z","timestamp":1760486400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T00:00:00Z","timestamp":1760486400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2021YFA1301304"],"award-info":[{"award-number":["2021YFA1301304"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82170557"],"award-info":[{"award-number":["82170557"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gut Pathog"],"DOI":"10.1186\/s13099-025-00752-x","type":"journal-article","created":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T09:08:42Z","timestamp":1760519322000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Exploring the role of gut microbiota in inflammatory bowel disease patients comorbid with non-alcoholic fatty liver disease"],"prefix":"10.1186","volume":"17","author":[{"given":"Jiachen","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuzhu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junxia","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liping","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,15]]},"reference":[{"issue":"8","key":"752_CR1","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.1097\/MIB.0000000000000429","volume":"21","author":"SR Vavricka","year":"2015","unstructured":"Vavricka SR, Rogler G, Gantenbein C, Spoerri M, Prinz Vavricka M, Navarini AA, et al. Chronological order of appearance of extraintestinal manifestations relative to the time of IBD diagnosis in the Swiss inflammatory bowel disease cohort. Inflamm Bowel Dis. 2015;21(8):1794\u2013800.","journal-title":"Inflamm Bowel Dis"},{"issue":"10290","key":"752_CR2","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1016\/S0140-6736(20)32511-3","volume":"397","author":"EE Powell","year":"2021","unstructured":"Powell EE, Wong VW, Rinella M. Non-alcoholic fatty liver disease. Lancet (London England). 2021;397(10290):2212\u201324.","journal-title":"Lancet (London England)"},{"issue":"8","key":"752_CR3","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1111\/apt.16879","volume":"55","author":"M Zamani","year":"2022","unstructured":"Zamani M, Alizadeh-Tabari S, Singh S, Loomba R. Meta-analysis: prevalence of, and risk factors for, non-alcoholic fatty liver disease in patients with inflammatory bowel disease. Aliment Pharmacol Ther. 2022;55(8):894\u2013907.","journal-title":"Aliment Pharmacol Ther"},{"issue":"6","key":"752_CR4","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1097\/MIB.0000000000001085","volume":"23","author":"K Glassner","year":"2017","unstructured":"Glassner K, Malaty HM, Abraham BP. Epidemiology and risk factors of nonalcoholic fatty liver disease among patients with inflammatory bowel disease. Inflamm Bowel Dis. 2017;23(6):998\u20131003.","journal-title":"Inflamm Bowel Dis"},{"issue":"2","key":"752_CR5","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.cgh.2022.01.039","volume":"21","author":"JC Rodriguez-Duque","year":"2023","unstructured":"Rodriguez-Duque JC, Calleja JL, Iruzubieta P, Hern\u00e1ndez-Conde M, Rivas-Rivas C, Vera MI, Garcia MJ, Pascual M, Castro B, Garc\u00eda-Blanco A, et al. Increased risk of MAFLD and liver fibrosis in inflammatory bowel disease independent of classic metabolic risk factors. Clin Gastroenterol Hepatology: Official Clin Pract J Am Gastroenterological Association. 2023;21(2):406\u2013e414407.","journal-title":"Clin Gastroenterol Hepatology: Official Clin Pract J Am Gastroenterological Association"},{"key":"752_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25105453","author":"C De Caro","year":"2024","unstructured":"De Caro C, Spagnuolo R, Quirino A, Mazza E, Carrabetta F, Maurotti S, et al. Gut microbiota profile changes in patients with inflammatory bowel disease and non-alcoholic fatty liver disease: a metagenomic study. Int J Mol Sci. 2024 May 17;25(10):5453. https:\/\/doi.org\/10.3390\/ijms25105453","journal-title":"Int J Mol Sci"},{"issue":"7","key":"752_CR7","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1053\/j.gastro.2019.12.054","volume":"158","author":"V Azzu","year":"2020","unstructured":"Azzu V, Vacca M, Virtue S, Allison M, Vidal-Puig A. Adipose tissue-liver cross talk in the control of whole-body metabolism: implications in nonalcoholic fatty liver disease. Gastroenterology. 2020;158(7):1899\u2013912.","journal-title":"Gastroenterology"},{"key":"752_CR8","doi-asserted-by":"crossref","unstructured":"Chinese consensus on diagnosis and treatment in inflammatory bowel disease. (2018, Beijing). Journal of digestive diseases 2021, 22(6):298\u2013317.","DOI":"10.1111\/1751-2980.12994"},{"issue":"3","key":"752_CR9","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/S0016-5085(76)80163-1","volume":"70","author":"WR Best","year":"1976","unstructured":"Best WR, Becktel JM, Singleton JW, Kern F Jr. Development of a crohn\u2019s disease activity index. National cooperative crohn\u2019s disease study. Gastroenterology. 1976;70(3):439\u201344.","journal-title":"Gastroenterology"},{"issue":"2","key":"752_CR10","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1053\/j.gastro.2006.12.038","volume":"132","author":"G D\u2019Haens","year":"2007","unstructured":"D\u2019Haens G, Sandborn WJ, Feagan BG, Geboes K, Hanauer SB, Irvine EJ, L\u00e9mann M, Marteau P, Rutgeerts P, Sch\u00f6lmerich J, et al. A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis. Gastroenterology. 2007;132(2):763\u201386.","journal-title":"Gastroenterology"},{"issue":"1","key":"752_CR11","doi-asserted-by":"publisher","DOI":"10.1002\/imt2.1","volume":"1","author":"Y Chen","year":"2022","unstructured":"Chen Y, Li J, Zhang Y, Zhang M, Sun Z, Jing G, et al. Parallel-Meta suite: interactive and rapid microbiome data analysis on multiple platforms. iMeta. 2022;1(1):e1.","journal-title":"iMeta"},{"issue":"12","key":"752_CR12","doi-asserted-by":"publisher","first-page":"2639","DOI":"10.1038\/ismej.2017.119","volume":"11","author":"BJ Callahan","year":"2017","unstructured":"Callahan BJ, McMurdie PJ, Holmes SP. Exact sequence variants should replace operational taxonomic units in marker-gene data analysis. ISME J. 2017;11(12):2639\u201343.","journal-title":"ISME J"},{"issue":"16","key":"752_CR13","doi-asserted-by":"publisher","first-page":"2194","DOI":"10.1093\/bioinformatics\/btr381","volume":"27","author":"RC Edgar","year":"2011","unstructured":"Edgar RC, Haas BJ, Clemente JC, Quince C, Knight R. Uchime improves sensitivity and speed of chimera detection. Bioinformatics. 2011;27(16):2194\u2013200.","journal-title":"Bioinformatics"},{"key":"752_CR14","doi-asserted-by":"publisher","first-page":"e2584","DOI":"10.7717\/peerj.2584","volume":"4","author":"T Rognes","year":"2016","unstructured":"Rognes T, Flouri T, Nichols B, Quince C, Mah\u00e9 F. VSEARCH: a versatile open source tool for metagenomics. PeerJ. 2016;4:e2584.","journal-title":"PeerJ"},{"issue":"11","key":"752_CR15","doi-asserted-by":"publisher","first-page":"e0206450","DOI":"10.1371\/journal.pone.0206450","volume":"13","author":"LC Adams","year":"2018","unstructured":"Adams LC, L\u00fcbbe F, Bressem K, Wagner M, Hamm B, Makowski MR. Non-alcoholic fatty liver disease in underweight patients with inflammatory bowel disease: a case-control study. PLoS ONE. 2018;13(11):e0206450.","journal-title":"PLoS ONE"},{"issue":"1","key":"752_CR16","doi-asserted-by":"publisher","first-page":"7135","DOI":"10.1038\/s41467-023-42788-0","volume":"14","author":"L Ning","year":"2023","unstructured":"Ning L, Zhou YL, Sun H, Zhang Y, Shen C, Wang Z, Xuan B, Zhao Y, Ma Y, Yan Y, et al. Microbiome and metabolome features in inflammatory bowel disease via multi-omics integration analyses across cohorts. Nat Commun. 2023;14(1):7135.","journal-title":"Nat Commun"},{"issue":"1","key":"752_CR17","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1038\/s41598-018-19753-9","volume":"8","author":"HE Da Silva","year":"2018","unstructured":"Da Silva HE, Teterina A, Comelli EM, Taibi A, Arendt BM, Fischer SE, Lou W, Allard JP. Nonalcoholic fatty liver disease is associated with dysbiosis independent of body mass index and insulin resistance. Sci Rep. 2018;8(1):1466.","journal-title":"Sci Rep"},{"issue":"6","key":"752_CR18","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1093\/ibd\/izab199","volume":"28","author":"S Noorian","year":"2022","unstructured":"Noorian S, Jeon Y, Nguyen MT, Sauk J, Limketkai BN. The impact of NAFLD on hospitalization outcomes in patients with inflammatory bowel diseases: nationwide analysis. Inflamm Bowel Dis. 2022;28(6):878\u201387.","journal-title":"Inflamm Bowel Dis"},{"issue":"10","key":"752_CR19","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1097\/MEG.0000000000002607","volume":"35","author":"A Boustany","year":"2023","unstructured":"Boustany A, Rahhal R, Mitri J, Onwuzo S, Abou Zeid HK, Baffy G, et al. The impact of nonalcoholic fatty liver disease on inflammatory bowel disease-related hospitalization outcomes: a systematic review. Eur J Gastroenterol Hepatol. 2023;35(10):1067\u201374.","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"5","key":"752_CR20","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.1007\/s00394-020-02431-w","volume":"60","author":"W Liu","year":"2021","unstructured":"Liu W, Luo X, Tang J, Mo Q, Zhong H, Zhang H, et al. A bridge for short-chain fatty acids to affect inflammatory bowel disease, type 1 diabetes, and non-alcoholic fatty liver disease positively: by changing gut barrier. Eur J Nutr. 2021;60(5):2317\u201330.","journal-title":"Eur J Nutr"},{"key":"752_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10030524","author":"Q Song","year":"2022","unstructured":"Song Q, Zhang X. The role of gut-liver axis in gut microbiome dysbiosis associated NAFLD and NAFLD-HCC. Biomedicines. 2022 Feb 23;10(3):524. https:\/\/doi.org\/10.3390\/biomedicines10030524","journal-title":"Biomedicines"},{"issue":"3","key":"752_CR22","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1007\/s10620-020-06715-3","volume":"66","author":"S Fiorucci","year":"2021","unstructured":"Fiorucci S, Carino A, Baldoni M, Santucci L, Costanzi E, Graziosi L, Distrutti E, Biagioli M. Bile acid signaling in inflammatory bowel diseases. Dig Dis Sci. 2021;66(3):674\u201393.","journal-title":"Dig Dis Sci"},{"key":"752_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2022.1089359","volume":"9","author":"H Bing","year":"2022","unstructured":"Bing H, Li YL. The role of bile acid metabolism in the occurrence and development of NAFLD. Front Mol Biosci. 2022;9:1089359.","journal-title":"Front Mol Biosci"},{"issue":"1","key":"752_CR24","doi-asserted-by":"publisher","first-page":"684","DOI":"10.3390\/ijms15010684","volume":"15","author":"F Del Chierico","year":"2014","unstructured":"Del Chierico F, Gnani D, Vernocchi P, Petrucca A, Alisi A, Dallapiccola B, et al. Meta-omic platforms to assist in the understanding of NAFLD gut microbiota alterations: tools and applications. Int J Mol Sci. 2014;15(1):684\u2013711.","journal-title":"Int J Mol Sci"},{"key":"752_CR25","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms9040854","author":"E Climent","year":"2021","unstructured":"Climent E, Martinez-Blanch JF, Llobregat L, Ruzafa-Costas B, Carri\u00f3n-Guti\u00e9rrez M, Ram\u00edrez-Bosc\u00e1 A, et al. Changes in gut microbiota correlates with response to treatment with probiotics in patients with atopic dermatitis. A post hoc analysis of a clinical trial. Microorganisms. 2021 Apr 15;9(4):854. https:\/\/doi.org\/10.3390\/microorganisms9040854","journal-title":"Microorganisms"},{"issue":"1","key":"752_CR26","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1186\/s13059-024-03390-9","volume":"25","author":"J Wirbel","year":"2024","unstructured":"Wirbel J, Essex M, Forslund SK, Zeller G. A realistic benchmark for differential abundance testing and confounder adjustment in human microbiome studies. Genome Biol. 2024;25(1):247.","journal-title":"Genome Biol"},{"issue":"4","key":"752_CR27","doi-asserted-by":"publisher","first-page":"e58","DOI":"10.1002\/imt2.58","volume":"1","author":"R Abdugheni","year":"2022","unstructured":"Abdugheni R, Wang WZ, Wang YJ, Du MX, Liu FL, Zhou N, Jiang CY, Wang CY, Wu L, Ma J, et al. Metabolite profiling of human-originated lachnospiraceae at the strain level. iMeta. 2022;1(4):e58.","journal-title":"iMeta"},{"key":"752_CR28","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms11102527","author":"E Martinez","year":"2023","unstructured":"Martinez E, Crevecoeur S, Thirion C, Grandjean J, Fall PA, Hayette MP, et al. Gut microbiota associated with clostridioides difficile carriage in three clinical groups (inflammatory bowel disease, C. difficile infection and healthcare workers) in hospital field. Microorganisms. 2023 Oct 10;11(10):2527. https:\/\/doi.org\/10.3390\/microorganisms11102527","journal-title":"Microorganisms"},{"issue":"1","key":"752_CR29","doi-asserted-by":"publisher","first-page":"2338244","DOI":"10.1080\/07853890.2024.2338244","volume":"56","author":"S Hertz","year":"2024","unstructured":"Hertz S, Anderson JM, Nielsen HL, Schachtschneider C, McCauley KE, \u00d6z\u00e7am M, Larsen L, Lynch SV, Nielsen H. Fecal microbiota is associated with extraintestinal manifestations in inflammatory bowel disease. Ann Med. 2024;56(1):2338244.","journal-title":"Ann Med"},{"issue":"7","key":"752_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2024.101624","volume":"5","author":"W Chen","year":"2024","unstructured":"Chen W, Li Y, Wang W, Gao S, Hu J, Xiang B, et al. Enhanced microbiota profiling in patients with quiescent Crohn\u2019s disease through comparison with paired healthy first-degree relatives. Cell Rep Med. 2024;5(7):101624.","journal-title":"Cell Rep Med"},{"issue":"22","key":"752_CR31","doi-asserted-by":"publisher","first-page":"11715","DOI":"10.1039\/D2FO01973F","volume":"13","author":"S Li","year":"2022","unstructured":"Li S, Zhou L, Zhang Q, Yu M, Xiao X. Genistein improves glucose metabolism and promotes adipose tissue browning through modulating gut microbiota in mice. Food Funct. 2022;13(22):11715\u201332.","journal-title":"Food Funct"},{"key":"752_CR32","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jafc.2c06697","author":"R Yang","year":"2023","unstructured":"Yang R, Shan S, Shi J, Li H, An N, Li S, et al. Coprococcus eutactus, a potent probiotic, alleviates colitis via acetate-mediated IgA response and microbiota restoration. J Agric Food Chem. 2023. https:\/\/doi.org\/10.1021\/acs.jafc.2c06697.","journal-title":"J Agric Food Chem"},{"issue":"1","key":"752_CR33","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s12944-021-01440-w","volume":"20","author":"F Li","year":"2021","unstructured":"Li F, Ye J, Shao C, Zhong B. Compositional alterations of gut microbiota in nonalcoholic fatty liver disease patients: a systematic review and meta-analysis. Lipids Health Dis. 2021;20(1):22.","journal-title":"Lipids Health Dis"},{"issue":"3","key":"752_CR34","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1002\/hep.31417","volume":"73","author":"LJM Alferink","year":"2021","unstructured":"Alferink LJM, Radjabzadeh D, Erler NS, Vojinovic D, Medina-Gomez C, Uitterlinden AG, et al. Microbiomics, metabolomics, predicted metagenomics, and hepatic steatosis in a population-based study of 1,355 adults. Hepatology. 2021;73(3):968\u201382.","journal-title":"Hepatology"},{"key":"752_CR35","doi-asserted-by":"publisher","DOI":"10.1093\/jambio\/lxae125","author":"K Lu","year":"2024","unstructured":"Lu K, Zhou Y, He L, Li Y, Shahzad M, Li D. Coprococcus protects against high-fat diet-induced nonalcoholic fatty liver disease in mice. J Appl Microbiol. 2024 Jun 3;135(6):lxae125. https:\/\/doi.org\/10.1093\/jambio\/lxae125","journal-title":"J Appl Microbiol"},{"key":"752_CR36","doi-asserted-by":"crossref","unstructured":"Saez-Lara MJ, Gomez-Llorente C, Plaza-Diaz J, Gil A. The role of probiotic lactic acid bacteria and bifidobacteria in the prevention and treatment of inflammatory bowel disease and other related diseases: a systematic review of randomized human clinical trials. BioMed research international 2015, 2015:505878.","DOI":"10.1155\/2015\/505878"},{"issue":"2","key":"752_CR37","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1007\/s12602-023-10041-1","volume":"16","author":"GM Campos","year":"2024","unstructured":"Campos GM, Am\u00e9rico MF, Dos Santos Freitas A, Barroso FAL, da Cruz Ferraz Dutra J, Quaresma LS, et al. Lactococcus lactis as an interleukin delivery system for prophylaxis and treatment of inflammatory and autoimmune diseases. Probiotics Antimicrob Proteins. 2024;16(2):352\u201366.","journal-title":"Probiotics Antimicrob Proteins"},{"issue":"8","key":"752_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-019-0293-4","volume":"51","author":"HR Jang","year":"2019","unstructured":"Jang HR, Park HJ, Kang D, Chung H, Nam MH, Lee Y, et al. A protective mechanism of probiotic Lactobacillus against hepatic steatosis via reducing host intestinal fatty acid absorption. Exp Mol Med. 2019;51(8):1\u201314.","journal-title":"Exp Mol Med"},{"issue":"1","key":"752_CR39","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1186\/s40168-024-01896-9","volume":"12","author":"S Zhang","year":"2024","unstructured":"Zhang S, Nie Q, Sun Y, Zuo S, Chen C, Li S, et al. Bacteroides uniformis degrades \u03b2-glucan to promote Lactobacillus johnsonii improving indole-3-lactic acid levels in alleviating colitis. Microbiome. 2024;12(1):177.","journal-title":"Microbiome"},{"issue":"25","key":"752_CR40","doi-asserted-by":"publisher","first-page":"e38551","DOI":"10.1097\/MD.0000000000038551","volume":"103","author":"YL Huang","year":"2024","unstructured":"Huang YL, Zheng JM, Shi ZY, Chen HH, Wang XT, Kong FB. Inflammatory proteins may mediate the causal relationship between gut microbiota and inflammatory bowel disease: a mediation and multivariable Mendelian randomization study. Medicine. 2024;103(25):e38551.","journal-title":"Medicine"},{"issue":"1","key":"752_CR41","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1186\/s12876-024-03277-w","volume":"24","author":"C Ouyang","year":"2024","unstructured":"Ouyang C, Liu P, Liu Y, Lan J, Liu Q. Metabolites mediate the causal associations between gut microbiota and NAFLD: a Mendelian randomization study. BMC Gastroenterol. 2024;24(1):244.","journal-title":"BMC Gastroenterol"},{"issue":"6","key":"752_CR42","doi-asserted-by":"publisher","DOI":"10.1002\/jbt.23738","volume":"38","author":"U Kulhari","year":"2024","unstructured":"Kulhari U, Rajanan A, Ambujakshan A, Verma S, Mugale MN, Sahu BD. Biochanin A mitigates ulcerative colitis and intestinal inflammation in mice by inhibiting MAPK\/NF-kB (p65) axis. J Biochem Mol Toxicol. 2024;38(6):e23738.","journal-title":"J Biochem Mol Toxicol"},{"issue":"23","key":"752_CR43","doi-asserted-by":"publisher","first-page":"5853","DOI":"10.1021\/acs.jafc.8b01691","volume":"66","author":"W Wang","year":"2018","unstructured":"Wang W, Chen J, Mao J, Li H, Wang M, Zhang H, et al. Genistein ameliorates non-alcoholic fatty liver disease by targeting the thromboxane A(2) pathway. J Agric Food Chem. 2018;66(23):5853\u20139.","journal-title":"J Agric Food Chem"},{"key":"752_CR44","doi-asserted-by":"publisher","DOI":"10.1111\/bph.17435","author":"X Pan","year":"2025","unstructured":"Pan X, Ren Z, Liang W, Dong X, Li J, Wang L, et al. Thiamine deficiency aggravates experimental colitis in mice by promoting glycolytic reprogramming in macrophages. Br J Pharmacol. 2025. https:\/\/doi.org\/10.1111\/bph.17435.","journal-title":"Br J Pharmacol"},{"key":"752_CR45","doi-asserted-by":"publisher","DOI":"10.1242\/dmm.048355","author":"M Kalyesubula","year":"2021","unstructured":"Kalyesubula M, Mopuri R, Asiku J, Rosov A, Yosefi S, Edery N, et al. High-dose vitamin B1 therapy prevents the development of experimental fatty liver driven by overnutrition. Dis Model Mech. 2021 Mar 18;14(3):dmm048355. https:\/\/doi.org\/10.1242\/dmm.048355","journal-title":"Dis Model Mech"},{"issue":"1","key":"752_CR46","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-020-00884-z","volume":"8","author":"Y Li","year":"2020","unstructured":"Li Y, Luo ZY, Hu YY, Bi YW, Yang JM, Zou WJ, et al. The gut microbiota regulates autism-like behavior by mediating vitamin B(6) homeostasis in EphB6-deficient mice. Microbiome. 2020;8(1):120.","journal-title":"Microbiome"},{"issue":"3","key":"752_CR47","doi-asserted-by":"publisher","first-page":"249","DOI":"10.3350\/cmh.2017.0019","volume":"23","author":"Y Ferro","year":"2017","unstructured":"Ferro Y, Car\u00e8 I, Mazza E, Provenzano F, Colica C, Torti C, Romeo S, Pujia A, Montalcini T. Protein and vitamin B6 intake are associated with liver steatosis assessed by transient elastography, especially in obese individuals. Clin Mol Hepatol. 2017;23(3):249\u201359.","journal-title":"Clin Mol Hepatol"},{"key":"752_CR48","doi-asserted-by":"crossref","unstructured":"Shen H, Zhou L, Yang Y, Shu H, Wu D, Yang S, Xie L, Yang L, Tian S, Zhang X et al. The gut microbiota-produced vitamin B6 mitigates alcohol-associated liver disease by attenuating hepatic oxidative stress damage. Hepatol Commun 2024 Dec 11;9(1):e0599.","DOI":"10.1097\/HC9.0000000000000599"},{"issue":"Pt 2","key":"752_CR49","doi-asserted-by":"publisher","first-page":"118879","DOI":"10.1016\/j.jep.2024.118879","volume":"337","author":"J Liu","year":"2025","unstructured":"Liu J, Wei F, Liu J, Sun W, Liu S, Chen S, et al. Protective effects and mechanisms of Hudichangrong capsule on TNBS-induced ulcerative colitis in mice. J Ethnopharmacol. 2025;337(Pt 2):118879.","journal-title":"J Ethnopharmacol"},{"key":"752_CR50","doi-asserted-by":"publisher","first-page":"817600","DOI":"10.3389\/fimmu.2022.817600","volume":"13","author":"H Cheng","year":"2022","unstructured":"Cheng H, Liu J, Zhang D, Wang J, Tan Y, Feng W, et al. Ginsenoside Rg1 alleviates acute ulcerative colitis by modulating gut microbiota and microbial tryptophan metabolism. Front Immunol. 2022;13:817600.","journal-title":"Front Immunol"},{"issue":"12","key":"752_CR51","doi-asserted-by":"publisher","first-page":"2138","DOI":"10.1016\/j.jnutbio.2013.08.005","volume":"24","author":"J Selhub","year":"2013","unstructured":"Selhub J, Byun A, Liu Z, Mason JB, Bronson RT, Crott JW. Dietary vitamin B6 intake modulates colonic inflammation in the IL10-\/- model of inflammatory bowel disease. J Nutr Biochem. 2013;24(12):2138\u201343.","journal-title":"J Nutr Biochem"},{"key":"752_CR52","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.nutres.2018.06.007","volume":"57","author":"A Aguilera-Mendez","year":"2018","unstructured":"Aguilera-Mendez A, Hern\u00e1ndez-Equihua MG, Rueda-Rocha AC, Guajardo-L\u00f3pez C, Nieto-Aguilar R, Serrato-Ochoa D, Ru\u00edz Herrera LF, Guzm\u00e1n-Nateras JA. Protective effect of supplementation with biotin against high-fructose-induced metabolic syndrome in rats. Nutr Res (New York NY). 2018;57:86\u201396.","journal-title":"Nutr Res (New York NY)"},{"key":"752_CR53","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11041118","author":"J Erbach","year":"2022","unstructured":"Erbach J, Bonn F, Diesner M, Arnold A, Stein J, Schr\u00f6der O, et al. Relevance of biotin deficiency in patients with inflammatory bowel disease and utility of serum 3 hydroxyisovaleryl carnitine as a practical everyday marker. J Clin Med. 2022 Feb 20;11(4):1118. https:\/\/doi.org\/10.3390\/jcm11041118","journal-title":"J Clin Med"},{"issue":"4","key":"752_CR54","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/j.jcmgh.2019.11.011","volume":"9","author":"J Skupsky","year":"2020","unstructured":"Skupsky J, Sabui S, Hwang M, Nakasaki M, Cahalan MD, Said HM. Biotin supplementation ameliorates murine colitis by preventing NF-\u03baB activation. Cell Mol Gastroenterol Hepatol. 2020;9(4):557\u201367.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"752_CR55","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1215329","volume":"14","author":"AG Gravina","year":"2023","unstructured":"Gravina AG, Pellegrino R, Palladino G, Coppola A, Brandimarte G, Tuccillo C, et al. Hericium erinaceus, in combination with natural flavonoid\/alkaloid and B(3)\/B(8) vitamins, can improve inflammatory burden in inflammatory bowel diseases tissue: an ex vivo study. Front Immunol. 2023;14:1215329.","journal-title":"Front Immunol"},{"key":"752_CR56","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2023.1141156","volume":"10","author":"B Yao","year":"2023","unstructured":"Yao B, Lu X, Xu L, Jiang Y. Association of serum folate with prevalence of non-alcoholic fatty liver disease among adults (NHANES 2011\u20132018). Front Nutr. 2023;10:1141156.","journal-title":"Front Nutr"},{"issue":"1","key":"752_CR57","doi-asserted-by":"publisher","first-page":"12933","DOI":"10.1038\/s41598-023-39641-1","volume":"13","author":"HK Chen","year":"2023","unstructured":"Chen HK, Luo J, Li XJ, Liao WZ, Hu YQ, Guo XG. Serum folate associated with nonalcoholic fatty liver disease and advanced hepatic fibrosis. Sci Rep. 2023;13(1):12933.","journal-title":"Sci Rep"},{"issue":"Suppl 1","key":"752_CR58","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1159\/000505368","volume":"101","author":"P Schreiner","year":"2020","unstructured":"Schreiner P, Martinho-Grueber M, Studerus D, Vavricka SR, Tilg H, Biedermann L. Nutrition in inflammatory bowel disease. Digestion. 2020;101(Suppl 1):120\u201335.","journal-title":"Digestion"}],"container-title":["Gut Pathogens"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13099-025-00752-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13099-025-00752-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13099-025-00752-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T10:03:09Z","timestamp":1760522589000},"score":1,"resource":{"primary":{"URL":"https:\/\/gutpathogens.biomedcentral.com\/articles\/10.1186\/s13099-025-00752-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,15]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["752"],"URL":"https:\/\/doi.org\/10.1186\/s13099-025-00752-x","relation":{},"ISSN":["1757-4749"],"issn-type":[{"value":"1757-4749","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,15]]},"assertion":[{"value":"7 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki and approved by the Ethics Committee of Peking University Third Hospital (Approval No. M2020447). Informed consent was obtained from all the subjects involved in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"81"}}